Form 10-K For the fiscal year ended December 2, 2023
We note Project One was approved in 2012 and will continue beyond 2024. We note the execution of Project One is being supported by internal resources and consulting services. We note your organizational realignment includes costs incurred as a direct result of the organizational realignment program, including compensation for employees supporting the program, consulting expense and operational inefficiencies.Rest of the question
We note you have approved restructuring “plans” in 2023, and previously complete plans include the 2020 Restructuring Plan, the 2017 Restructuring Plan, and the Royal Adhesives Restructuring Plan. We note acquisition project costs include costs related to integrating and accounting for acquisitions and there were approximately ten acquisitions over the past two fiscal years. We note you have previously provided information to the staff via your response letter dated April 30, 2021 and that certain of these expenses have become more significant since then and that currently certain of the descriptions related to the non- GAAP adjustments lack sufficient detail that would allow investors to fully assess your non-GAAP measure. As it relates to the acquisition project costs, organizational realignment costs and Project One costs included within your reconciliation to Adjusted net income attributable to H.B. Fuller, please more fully describe the nature of the specific costs that were incurred and any relevant details to understand the context of the costs being incurred. Please quantify any material categories within these non-GAAP adjustments. Please provide us any proposed changes. In addition, please reconcile for us the amount of acquisition project costs and organizational realignment costs presented here with the amount in Note 3: Restructuring Activities, of your financial statements.
Acquisition project costs consist of transaction, purchase accounting and business integration costs. Transaction costs include consulting and professional fees, representations and warranties insurance premiums and employee acquisition-related travel expenses. Purchase accounting costs include professional fees for valuation services, inventory step-up cost and the impact of changes in contingent consideration liabilities after the completion of the purchase price allocation.Read in the replyRest of the answer
Business integration costs include the cost of transitional services and retention plan costs for acquired employees.
Organization realignment costs consist of professional fees related to legal entity and business structure changes, employee retention and severance costs, and facility rationalization costs related to the closure of production facilities and consolidation of business activities. Facility rationalization costs include plant closure costs, the impact of accelerated depreciation, and operational inefficiencies.
Project ONE costs consist of non-capitalizable consulting fees and internal employee compensation and travel costs related to the design and implementation of our SAP ERP system.
In accordance with the Staff’s comment, in future earnings releases, we will more fully describe the above costs included in our reconciliation of Adjusted net income attributable to H.B. Fuller to Net income attributable to H.B. Fuller. Additionally, we will quantify material categories within those non-GAAP adjustments. An example of the disclosures to be included in our future earnings releases is presented below.
H.B. FULLER COMPANY AND SUBSIDIARIES
REGULATION G RECONCILIATION
In thousands, except per share amounts (unaudited)
Three Months Ended
Year Ended
December
2,
3,
2023
2022
Net income attributable to H.B. Fuller
$
44,991
48,305
144,906
180,313
Adjustments:
Acquisition project costs 1
4,765
1,822
16,874
10,830
Organizational realignment 2
10,549
1,471
29,900
6,386
Royal restructuring and integration 3
-
1,467
2,474
Project One 4
2,193
2,326
9,815
9,885
Other 5
(3,903
)
4,524
(611
12,791
Discrete tax items 6
16,955
1,610
26,085
9,308
Income tax effect on adjustments 7
(1,158
(3,911
(10,604
(10,699
Adjusted net income attributable to H.B. Fuller 8
74,392
57,614
216,365
221,288
Add:
Interest expense
33,297
30,046
131,913
91,547
Interest income
(1,217
(1,609
(3,943
(7,790
Income taxes
26,477
17,464
78,047
78,576
Depreciation and Amortization expense 9
39,653
37,469
158,456
146,394
Adjusted EBITDA 8
172,602
140,984
580,838
530,015
Diluted Shares
56,161
55,472
55,958
55,269
Adjusted diluted income per common share attributable to H.B. Fuller 8
1.32
1.04
3.87
4.00
Adjusted net revenue
902,879
958,213
3,510,934
3,749,183
Adjusted EBITDA margin 8
19.1
%
14.7
16.5
14.1
1 Acquisition project costs include costs related to evaluating, acquiring and integrating business acquisitions. Acquisition project costs include $1,421 and $1,090 in transaction costs (primarily consulting and professional fees, representations and warranties insurance premiums and employee acquisition-related travel expenses), $1,489 and $732 in purchasing accounting costs (primarily professional fees for valuation services, inventory step-up cost and the impact of changes to contingent consideration liabilities after the completion of the purchase price allocation) and $1,855 and $0 in business integration costs (primarily costs of transition services agreements and retention bonuses paid to employees of the acquired entities) for the three months ended December 2, 2023 and December 3, 2022, respectively. Acquisition project costs include $6,960 and $8,824 in transaction costs (primarily consulting and professional fees, representations and warranties insurance premiums and employee acquisition related travel expenses), $7,712 and $2,006 in purchasing accounting costs (primarily professional fees for valuation services, inventory step-up cost and the impact of changes to contingent consideration liabilities after the completion of the purchase price allocation) and $2,202 and $0 in business integration costs (primarily costs of transition services agreements and retention bonuses paid to employees of the acquired entities) for the years ended December 2, 2023 and December 3, 2022, respectively.
2 Organizational realignment includes costs incurred as a direct result of the organizational realignment program, including professional fees related to legal entity and business structure changes, employee retention and severance costs, and facility rationalization costs related to the closure of production facilities and consolidation of business activities. Facility rationalization costs include plant closure costs, the impact of accelerated depreciation, and operational inefficiencies. Organizational realignment includes $812 and $240 in professional fees related to legal entity and business structure changes, $8,110 and $1,105 in employee severance and other related costs, and $1,627 and $126 related to facility rationalization costs for the three months ended December 2, 2023 and December 3, 2022, respectively. Organizational realignment includes $1,525 and $2,484 in professional fees related to legal entity and business structure changes, $25,490 and $3,105 in employee severance and other related costs, and $2,885 and $797 related to facility rationalization costs for the year ended December 2, 2023 and December 3, 2022, respectively.
3 Royal restructuring and integration program includes costs incurred as a direct result of the Royal restructuring and integration program including professional fees related to the restructuring and operational inefficiencies related to the closure of production facilities and consolidation of business activities.
4 Project One includes non-capitalizable project costs related implementing our global Enterprise Resource Planning system, including upgrading to SAP S/4HANA®, which will upgrade and standardize our information system.
As requested, a reconciliation of the adjustments contained in our Form 8-K compared to our disclosure in Note 3 to our Form 10-K related to the Organizational realignment and Royal restructuring and integration projects for fiscal year ended December 2, 2023 and December 3, 2022 is included below.
Fiscal year ended December 2, 2023
Form 10-K: Organizational realignment
24,587
Internal personnel and other costs
(311
Professional fees and other external costs
3,431
Operating inefficiencies
Form 8-K: Organizational realignment
Fiscal year ended December 3, 2022
(352
Form 10-K: Royal restructuring and integration
(97
First report after the company's reply of Apr 12, 2024: 10-Q filed Jun 27, 2024 ↗, against the 10-Q filed Sep 28, 2023 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Please explain to us why you present discrete tax items as an adjustment to determine Adjusted net income attributable to H.B. Fuller, separate and apart from your income taxes adjustment to determine Adjusted EBITDA. In addition, please explain to us the circumstances related to earnings that are no longer invested.
The Company presents discrete tax items as an adjustment to determine adjusted net income attributable to H.B. Fuller separate from income tax adjustments to determine adjusted EBITDA because, in the Company’s view, those discrete tax items do not relate to current year adjusted pre-tax earnings. The discrete tax items, like the other adjustments used to determine adjusted net income attributable to H.B. Fuller, are generally non-recurring or otherwise not directly related to current year earnings.Read in the replyRest of the answer
The income tax adjustments used to determine adjusted EBITDA, on the other hand, represent tax impacts related to current period earnings that are added back to adjusted net income attributable to H.B. Fuller to arrive at adjusted EBITDA.
In calculating adjusted net income attributable to H.B. Fuller, the Company also adjusts for the income tax effects of the current year adjustments used to reconcile U.S. GAAP net income attributable to H.B. Fuller to adjusted net income attributable to H.B. Fuller. For fiscal year 2023, the discrete tax items of $26,085, income tax effect on adjustments of ($10,604) and income tax adjustments of $78,047, when taken together, equal the U.S. GAAP income tax expense of $93,529.
The circumstances related to earnings that are no longer invested involve the Company’s practice of not recording U.S. deferred income taxes for certain of its non-U.S. subsidiaries’ undistributed earnings because those amounts are intended to be indefinitely reinvested outside of the U.S. Company management continuously assesses the Company’s global and the individual non-U.S. subsidiary’s local cash needs in evaluating whether earnings are intended to be indefinitely reinvested. Potential cash needs include, without limitation, capital investment, working capital, repayment of debt and acquisitions. During the fourth quarter of fiscal year 2023, Company management concluded that it no longer intends to indefinitely reinvest a portion of the undistributed earnings held by certain of the Company’s non-U.S. subsidiaries. Based on that determination, the Company recorded withholding tax on those earnings.
First report after the company's reply of Apr 12, 2024: 10-Q filed Jun 27, 2024 ↗, against the 10-Q filed Sep 28, 2023 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note the headlines at the top of your news release refer to company achieves new record for Q4 and fiscal year adjusted EBITDA margin, and Q4 Adjusted EBITDA up 22% and Adjusted EBITDA margin up 440 basis points versus Q4 2022. Please tell us how you considered Non-GAAP Financial Measures C&DI 102.10(a) as it relates to the prominence of these non-GAAP measures in your news release.
The Company respectfully acknowledges the Staff’s comment and will revise its presentation of non-GAAP measures in future earnings releases, including in headlines, to include the comparable GAAP measure with equal or greater prominence as each non-GAAP measure in accordance with Non-GAAP Financial Measures C&DI 102.10(a).Read in the reply
First report after the company's reply of Apr 12, 2024: 10-Q filed Jun 27, 2024 ↗, against the 10-Q filed Sep 28, 2023 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note you attribute the 2023 300 basis points change in cost of sales and gross profit to lower raw material costs and higher product pricing partially offset by the impact of lower sales volume. Please provide us and in future filings more insight and specificity as it relates to each of these factors. For example, analyze and discuss the underlying raw materials and products at hand.Rest of the question
In addition, please provide quantitative information as it relates to the contribution of each factor to the basis point change. Refer to Item 303(a), (b), and (b)(2) of Regulation S-K for the relevant MD&A requirements.
In accordance with the Staff’s comment, in future filings the Company will provide more specificity and quantitative information related to the impact of sales volumes, product pricing, raw material costs and other manufacturing costs on cost of sales and gross margin. The Company respectfully notes for the Staff that it uses thousands of raw materials to produce thousands of products across diverse global and regional markets.Read in the replyRest of the answer
Therefore, in the Company’s opinion, a detailed disclosure regarding raw material costs and product pricing is not practical and would not provide meaningful information to the Company’s investors and other stakeholders as no individual raw material or product would have a significant effect on our financial results. An example of the more detailed disclosures to be included in our future filings is presented below.
Cost of sales
($ in millions)
2023 vs 2022
2,502.0
2,785.5
(10.2
)%
Percent of net revenue
71.3
74.3
Cost of sales in 2023 compared to 2022 decreased 300 basis points as a percentage of net revenue. Raw material cost as a percentage of net revenue decreased 440 basis points in 2023 compared to 2022 due to lower raw material costs. Other manufacturing costs as a percentage of net revenue increased 140 basis points in 2023 compared to 2022 due to lower sales volume partially offset by higher product pricing.
First report after the company's reply of Apr 12, 2024: 10-Q filed Jun 27, 2024 ↗, against the 10-Q filed Sep 28, 2023 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
In your separate discussions of segment operating income you make references to gross margin and SG&A, but these line items are not presented on a segment basis in your financial statements. Please provide additional quantitative information regarding the factors you cite in future filings.Rest of the question
In addition, please provide additional insight into your analysis of SG&A and gross margin, similarly as requested in the comment above. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
In accordance with the Staff’s comment, in future filings, the Company will provide more specificity and quantitative information regarding gross margin and SG&A on a segment basis. An example of the disclosures to be included in our future filings is presented below.Read in the reply
Hygiene, Health and Consumable Adhesives
Net revenue
1,601.5
1,695.9
(5.6
Segment operating income
215.1
165.8
29.7
Segment profit margin %
13.4
9.8
The following tables provide details of Hygiene, Health and Consumable Adhesives net revenue variances:
Organic revenue growth
(5.1
Extra week in 2022 (53-weekRest of the answer
year)
(1.8
M&A
4.6
Currency
(3.3
Net revenue growth
Net revenue decreased 5.6 percent in 2023 compared to 2022. The decrease in organic revenue growth was attributable to a decrease in sales volume, partially offset by an increase in product pricing. The 4.6 percent increase in net revenue from M&A was due to acquisitions of Lemtapes in the first quarter of 2023, Beardow Adams in the second quarter of 2023 and Adhezion in the third quarter of 2023. The negative currency effect was due to a weaker Egyptian pound, Turkish lira, Argentinian peso and Chinese renminbi offset by a stronger Mexican peso and Euro compared to the U.S. dollar. Additionally, net revenue in 2023 was lower than 2022 by 1.8 percent from an additional week of revenue in 2022 as it was a 53-week fiscal year compared to a 52-week fiscal year in 2023. As a percentage of net revenue, raw material costs decreased 590 basis points due to lower raw material costs. Other manufacturing costs as a percentage of net revenue increased 90 basis points due to lower sales volume partially offset by higher product pricing. SG&A expenses as a percentage of net revenue increased by 140 basis points due to the impact of acquisitions and lower net revenue. Segment operating income increased 29.7 percent and segment operating margin as a percentage of net revenue increased 360 basis points in 2023 as compared to 2022.
* * * * *
If you have any further questions or comments or would like clarification as to any of the information provided in this letter, please call me at (651) 236-5710 or Gregory Ogunsanya, Senior Vice President, General Counsel and Corporate Secretary of the Company, at (651) 242-4924. Thank you.
First report after the company's reply of Apr 12, 2024: 10-Q filed Jun 27, 2024 ↗, against the 10-Q filed Sep 28, 2023 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Also in this review: closing letter, 2024-05-02